Canada markets open in 3 hours 53 minutes

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.7400-0.0700 (-1.84%)
At close: 04:00PM EST
3.9200 +0.18 (+4.81%)
After hours: 06:59PM EST

Biomerica, Inc.

17571 Von Karman Avenue
Irvine, CA 92614
United States
949 645 2111
https://www.biomerica.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees64

Key Executives

NameTitlePayExercisedYear Born
Mr. Zackary S. IraniChairman & CEO135kN/A1966
Mr. Allen C. BarbieriExec. Vice-Chairman & Corp. Sec.197.96kN/A1958
Mr. Steven SloanCFO & Treasurer205kN/A1970
Ms. Lucy Liu Ph.D.Director of Manufacturing & Technical OperationsN/AN/AN/A
Hans BoehringerSr. VP of POC R&DN/AN/AN/A
Mr. Robert W. CarlsonChief Commercial OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Corporate Governance

Biomerica, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.